Skip to Main Content

Paper Details

Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
9
2021
Author NameAffiliation
Ann-Kathrin EisfeldOhio State University Comprehensive Cancer Center
Marlise R LuskinDana Farber Cancer Institute
Areej El-JawahriMassachusetts General Hospital
  • 1 - 3

Datasets

Release 1.2